Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. 2001

S Yerly, and S Vora, and P Rizzardi, and J P Chave, and P L Vernazza, and M Flepp, and A Telenti, and M Battegay, and A L Veuthey, and J P Bru, and M Rickenbach, and B Hirschel, and L Perrin, and
University Hospital of Geneva, 1211 Geneva 14, Switzerland.

OBJECTIVE To assess the impact of primary HIV infection (PHI) on the spread of HIV and the temporal trends in transmission of HIV drug resistance between 1996 and 1999 in Switzerland. METHODS Sequencing of the genes for reverse transcriptase (RT) and protease was performed for 197 individuals with documented PHI. Phylogenetic analyses were confronted with epidemiological data. RESULTS Significant clustering was demonstrated for 29% of the RT sequences. All these cases occurred closely together in place and time; contact tracing demonstrated transmission at the time of PHI in 30% of them. Genotypic drug resistance was detected in 8.6% of PHI individuals in 1996, 14.6% in 1997, 8.8% in 1998 and 5.0% in 1999. Drug-resistant variants were identified in 11.3% of individuals infected by homosexual contacts, 6.1% by heterosexual contacts, 13% of intravenous drug users and more frequently in men (10.4%) than women (2.6%). Potential factors involved in the recent decrease of transmission of drug-resistant variants include increase of HIV non-B subtypes from 23% in 1996 to 35% in 1999 (only one non-B subtype had resistance mutations) and a steady increase of patients with undetectable viraemia as documented in Swiss HIV Cohort Study (10% in 1996 vs 53% in 1999). CONCLUSIONS Phylogenetic and epidemiological analyses underline the impact of PHI in the spread of HIV. Moreover, this study indicates that drug resistance transmission may have decreased recently in Switzerland through the increased frequency of infection with HIV non-B subtypes and the steady increase of patients with undetectable viraemia.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010802 Phylogeny The relationships of groups of organisms as reflected by their genetic makeup. Community Phylogenetics,Molecular Phylogenetics,Phylogenetic Analyses,Phylogenetic Analysis,Phylogenetic Clustering,Phylogenetic Comparative Analysis,Phylogenetic Comparative Methods,Phylogenetic Distance,Phylogenetic Generalized Least Squares,Phylogenetic Groups,Phylogenetic Incongruence,Phylogenetic Inference,Phylogenetic Networks,Phylogenetic Reconstruction,Phylogenetic Relatedness,Phylogenetic Relationships,Phylogenetic Signal,Phylogenetic Structure,Phylogenetic Tree,Phylogenetic Trees,Phylogenomics,Analyse, Phylogenetic,Analysis, Phylogenetic,Analysis, Phylogenetic Comparative,Clustering, Phylogenetic,Community Phylogenetic,Comparative Analysis, Phylogenetic,Comparative Method, Phylogenetic,Distance, Phylogenetic,Group, Phylogenetic,Incongruence, Phylogenetic,Inference, Phylogenetic,Method, Phylogenetic Comparative,Molecular Phylogenetic,Network, Phylogenetic,Phylogenetic Analyse,Phylogenetic Clusterings,Phylogenetic Comparative Analyses,Phylogenetic Comparative Method,Phylogenetic Distances,Phylogenetic Group,Phylogenetic Incongruences,Phylogenetic Inferences,Phylogenetic Network,Phylogenetic Reconstructions,Phylogenetic Relatednesses,Phylogenetic Relationship,Phylogenetic Signals,Phylogenetic Structures,Phylogenetic, Community,Phylogenetic, Molecular,Phylogenies,Phylogenomic,Reconstruction, Phylogenetic,Relatedness, Phylogenetic,Relationship, Phylogenetic,Signal, Phylogenetic,Structure, Phylogenetic,Tree, Phylogenetic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013557 Switzerland A country in Europe. It is bordered by Austria, France, Italy, Liechtenstein, and Germany. The capital is Bern.

Related Publications

S Yerly, and S Vora, and P Rizzardi, and J P Chave, and P L Vernazza, and M Flepp, and A Telenti, and M Battegay, and A L Veuthey, and J P Bru, and M Rickenbach, and B Hirschel, and L Perrin, and
January 2014, Journal of theoretical biology,
S Yerly, and S Vora, and P Rizzardi, and J P Chave, and P L Vernazza, and M Flepp, and A Telenti, and M Battegay, and A L Veuthey, and J P Bru, and M Rickenbach, and B Hirschel, and L Perrin, and
July 2009, AIDS (London, England),
S Yerly, and S Vora, and P Rizzardi, and J P Chave, and P L Vernazza, and M Flepp, and A Telenti, and M Battegay, and A L Veuthey, and J P Bru, and M Rickenbach, and B Hirschel, and L Perrin, and
June 2023, AIDS (London, England),
S Yerly, and S Vora, and P Rizzardi, and J P Chave, and P L Vernazza, and M Flepp, and A Telenti, and M Battegay, and A L Veuthey, and J P Bru, and M Rickenbach, and B Hirschel, and L Perrin, and
March 2020, The Journal of antimicrobial chemotherapy,
S Yerly, and S Vora, and P Rizzardi, and J P Chave, and P L Vernazza, and M Flepp, and A Telenti, and M Battegay, and A L Veuthey, and J P Bru, and M Rickenbach, and B Hirschel, and L Perrin, and
August 2023, The Journal of antimicrobial chemotherapy,
S Yerly, and S Vora, and P Rizzardi, and J P Chave, and P L Vernazza, and M Flepp, and A Telenti, and M Battegay, and A L Veuthey, and J P Bru, and M Rickenbach, and B Hirschel, and L Perrin, and
January 2006, AIDS reviews,
S Yerly, and S Vora, and P Rizzardi, and J P Chave, and P L Vernazza, and M Flepp, and A Telenti, and M Battegay, and A L Veuthey, and J P Bru, and M Rickenbach, and B Hirschel, and L Perrin, and
October 2011, The Journal of antimicrobial chemotherapy,
S Yerly, and S Vora, and P Rizzardi, and J P Chave, and P L Vernazza, and M Flepp, and A Telenti, and M Battegay, and A L Veuthey, and J P Bru, and M Rickenbach, and B Hirschel, and L Perrin, and
June 2003, Proceedings of the National Academy of Sciences of the United States of America,
S Yerly, and S Vora, and P Rizzardi, and J P Chave, and P L Vernazza, and M Flepp, and A Telenti, and M Battegay, and A L Veuthey, and J P Bru, and M Rickenbach, and B Hirschel, and L Perrin, and
May 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
S Yerly, and S Vora, and P Rizzardi, and J P Chave, and P L Vernazza, and M Flepp, and A Telenti, and M Battegay, and A L Veuthey, and J P Bru, and M Rickenbach, and B Hirschel, and L Perrin, and
November 2000, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!